Throughout medicine personalized care is becoming an increasing focus of the field. This is no exception for the treatment of multiple sclerosis where patients may find a medication which works for a short time before needing to find a new option.
Drs. Lublin, Coyle, Markowitz, and Riley discuss issues of variability in data reported on treatment efficacy in multiple sclerosis and suggest how changes in clinical trial designs can provide healthcare professionals with more reliable insight into treating the disease.
Lifestyle factors and multiple sclerosis is a two-way street; but what does that mean for practicing physicians? Allen Bowling, MD, PhD, explains at the 2016 Annual Meeting of the Consortium of Multiple Sclerosis Center (CMSC) in National Harbor, Maryland.